App-Quantinova.ai

Apixaban in HVAD Patients Non-Compliant to Standard Vitamin-K-Antagonism

S. Schulte-Eistrup - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: The RAMP-IT-UP Multicenter Study

N. Uriel - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Concentrated Factor Administration and Subsequent Pump Thrombosis on HeartMate II LVAD Support

H. Shah - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rFVIIa

Features for Success: Factors Associated with Successful LVAD Outcomes at 1-Year Post Implant

L.C. Lohmueller - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

High Afterload Driving Poor Cardiac Output in LVAD Patients is Rectified with Nitrate Therapy

A. Rosenbaum - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A Trial of Complete Withdrawal of Anticoagulation Therapy in the Heartmate 3 Pump

I. Netuka - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Outcomes of Obese Patients Bridged to Heart Transplantation with Continuous-Flow Left Ventricular Assist Devices

A.K. Okoh - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Hemocompatibility-Related Adverse Events: Is the Burden Different among Available Centrifugal Flow Pumps?

K.A. Holst - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Unexpected Contribution of Pulsatility to Pump Thrombosis

J. Engelman - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Efficacy and Safety of Idarucizumab for Rapid Reversal from Dabigatran in Patients Undergoing Orthotopic Heart Transplantation

I. Kim - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Idarucizumab

Is Diabetes Mellitus a Risk Factor for Adverse Outcomes in Patients with Left Ventricular Assist Device? A Systematic Review and Meta-Analysis

P. Zhou - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Relationship between Inflow Malposition and Clinical Outcomes in HVAD Recipients

E.N. Sorensen - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Opioid Use in LVAD Patients is Associated with Increased GI Bleed and Sepsis

P. Combs - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Epimorph

Comparison of Unfractionated Heparin and Bivalirudin for Treatment of Suspected Device Thrombosis during Heart Mate II Support

K. Shah - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Aspirin: Therapy or Trouble for LVAD Patients?

R. Khedraki - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Incidence and Outcomes of Prosthetic Valve Thrombosis during Extracorporeal Membrane Oxygenation Support for Postcardiotomy Shock

M. Cevasco - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Recurrent Pump Thrombosis is Common after Axial Continuous Flow LVAD Exchange

C. Macdonald - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Novel Oral Anticoagulants in Patients with Continuous Flow Left Ventricular Assist Devices

V. Parikh - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

Level of Power Increase on Admission Determines Successful Treatment with Enhanced Anticoagulation with HeartWare Ventricular Assist Device Thrombosis

A. Woods - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Association of Post Implant Thromboelastogram and Left Ventricular Assist Device Thrombosis

C.L. Eshelbrenner - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts